ADVERUM BIOTECHNOLOGIES INC (ADVM) Earnings History & Surprises

NASDAQ:ADVM • US00773U2078

Current stock price

4.36 USD
+0.1 (+2.35%)
At close:
4.6 USD
+0.24 (+5.5%)
After Hours:

ADVM Earnings overview

Past quarterly earnings results for ADVERUM BIOTECHNOLOGIES INC (ADVM), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Mar 16, 2026
Period
Q4 / 2025
EPS Estimate
-$1.47
Revenue Estimate
339.997K

Last Reported

Most Recent
Release Date
Nov 12, 2025
Period
Q3 / 2025
EPS Reported
-$2.03
EPS Surprise
-26.10%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
19%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2025 -2.03 -1.61 -26.10% -56.15% - -100.00%
Q2 2025 -2.34 -2.29 -2.11% -162.92% - -
Q1 2025 -2.25 -1.85 -21.57% -50.00% - -
Q4 2024 -1.96 -1.39 -41.41% 14.78% - -
Q3 2024 -1.30 -1.33 2.50% 60.61% 1M 102K 880.39% -
Q2 2024 -0.89 -1.50 40.56% 71.29% 77.224K -100.00% -
Q1 2024 -1.50 -1.43 -4.70% 48.28% 74.317K -100.00% -100.00%
Q4 2023 -2.30 -3.43 33.02% 30.30% - -
Q3 2023 -3.30 -3.21 -2.65% 17.50% - -
Q2 2023 -3.10 -3.35 7.57% 29.55% - -
Q1 2023 -2.90 -3.27 11.26% 23.68% 3.6M - -
Q4 2022 -3.30 -3.70 10.73% 5.71% - -
Q3 2022 -4.00 -3.52 -13.67% -2.56% - -
Q2 2022 -4.40 -3.47 -26.87% 2.22% - -
Q1 2022 -3.80 -3.16 -20.18% -31.03% - -100.00%
Q4 2021 -3.50 -3.50 0.06% 10.26% - -
Q3 2021 -3.90 -3.83 -1.96% -25.81% - -
Q2 2021 -4.50 -3.97 -13.45% -25.00% - -
Q1 2021 -2.90 -3.89 25.40% 6.45% 7.5M 58.65K 12,687.72% -
Q4 2020 -3.90 -3.29 -18.38% - 78.203K -100.00% -
Q3 2020 -3.10 -3.50 11.48% - 67.024K -100.00% -
Q2 2020 -3.60 -2.89 -24.57% - 96.9K -100.00% -
Q1 2020 -3.10 -2.79 -10.92% - 86.129K -100.00% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

ADVM EPS Q2Q GrowthADVM EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 0 50 -50 -100 -150

Revenue Historical Q2Q growth and Acceleration

ADVM Revenue Q2Q GrowthADVM Revenue Q2Q GrowthRevenue Q2Q Growth Q1/22 Q1/24 Q3/25 Q4/26 -20 -40 -60 -80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
0
Average EPS beat (4)
-22.80%
Max EPS beat (4)
-2.11%
Min EPS beat (4)
-41.41%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, ADVM has not beaten EPS estimates in any release
In the last 4 quarters, ADVM reported -22.8% below the EPS estimates on average.
ADVM Overview ADVM Technical Analysis Report ADVM Fundamental Analysis Report ADVM Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

ADVERUM BIOTECHNOLOGIES INC / ADVM Earnings FAQ

What is the most recent earnings date for ADVM stock?

ADVERUM BIOTECHNOLOGIES INC (ADVM) last reported earnings on 11/12/2025.

Can you provide information on whether ADVERUM BIOTECHNOLOGIES INC beat earnings estimates in the last quarter?

ADVERUM BIOTECHNOLOGIES INC (ADVM) missed EPS estimates and missed revenue estimates in the most recent quarter.

How often does ADVERUM BIOTECHNOLOGIES INC (ADVM) beat earnings estimates?

In the last 4 quarters, ADVERUM BIOTECHNOLOGIES INC (ADVM) has beaten EPS estimates in 0 out of 4 releases.